Caution should be exercised in pregnant and breastfeeding women. Avoid excess dosage.
Indication
Intestinal amoebiasis
Contra Indication
Hypersensitivity.
Dose
N/A
Side Effect
The frequency of these side-effects is unknown
flatulence, itching, urticaria, vomiting
Pregnancy Category
Name :
Not Classified
Description
FDA has not yet classified the drug into a specified pregnancy category.
Mode of Action
Diloxanide is a luminal amoebicide which is hydrolysed in the gut, thus releasing the free diloxanide which acts as an amoebicide. It is given alone in asymptomatic cyst passers. For patients with active amoebic infections, it can be administered with a 5-nitroimidazole e.g. metronidazole or tinidazole.
Interaction
N/A
Pregnancy Category Note
N/A
Adult Dose
Oral
Intestinal amoebiasis
Adult: 500 mg tid for 10 days. May repeat course if needed.
Child Dose
Oral
Intestinal amoebiasis
Child: >25 kg: 20 mg/kg daily in 3 divided doses for 10 days, repeated if necessary.
Renal Dose
N/A
Administration
N/A
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.